The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase 2 study of galunisertib, a novel transforming growth factor-beta (TGF-β) receptor I kinase inhibitor, in patients with advanced hepatocellular carcinoma (HCC) and low serum alpha fetoprotein (AFP).
 
Sandrine J. Faivre
Consulting or Advisory Role - Lilly
Research Funding - Lilly
Travel, Accommodations, Expenses - Lilly
 
Armando Santoro
Consulting or Advisory Role - Amgen; ArQule; Bayer; Celgene; Lilly; Roche; Takeda
 
Edward Gane
No Relationships to Disclose
 
Robin Kate Kelley
Consulting or Advisory Role - Acceleron Pharma; Lilly
Research Funding - Celgene (Inst); Exelixis (Inst); Lilly (Inst); Novartis (Inst); Regeneron (Inst); Sanofi (Inst); Tekmira (Inst)
 
I Ollivier Hourmand
No Relationships to Disclose
 
Eric Assenat
No Relationships to Disclose
 
Ivelina Gueorguieva
Employment - Lilly
Stock and Other Ownership Interests - Lilly
 
Ann Cleverly
Employment - Lilly
Stock and Other Ownership Interests - Lilly
 
Durisala Desaiah
Employment - Lilly
Stock and Other Ownership Interests - Lilly
 
Michael M. F. Lahn
Employment - AstraZeneca; Lilly
Stock and Other Ownership Interests - Lilly
 
Eric Raymond
Consulting or Advisory Role - Lilly
Research Funding - Lilly
 
Karim A. Benhadji
Employment - Lilly
Stock and Other Ownership Interests - Lilly
 
Gianluigi Giannelli
Research Funding - Lilly